Fusion Pharmaceuticals Inc. Contracts & Agreements

53 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Employment Agreement between the Registrant and James OLeary, MD, to be in effect upon the closing of this offering
Employment Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
MA
2020
Employment Agreement between the Company and Eric Burak, Ph.D. (dated as of December 18, 2023)
Employment Agreements
Fusion Pharmaceuticals Inc.
2024
Arrangement Agreement dated as of March 18, 2024, among Fusion Pharmaceuticals Inc., AstraZeneca AB and 15863210 Canada Inc
Fusion Pharmaceuticals Inc.
2024
Amendment to the Employment Agreement, by and between Fusion Pharmaceuticals Inc. and Eric Burak, dated as of March 18, 2024
Employment Agreements
Fusion Pharmaceuticals Inc.
2024
License Agreement, dated February 16, 2024, among Fusion Pharmaceuticals Inc., Universitt Heidelberg and Euratom represented by the European Commission, Joint Research Centre
License Agreements
Fusion Pharmaceuticals Inc.
2024
Amendment No. 1 to Open Market Sale AgreementSM, dated January 19, 2024, by and between the Company and Jefferies LLC
Fusion Pharmaceuticals Inc.
2024
Securities Purchase Agreement, dated May 10, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Purchase Agreements
Fusion Pharmaceuticals Inc.
2023
Registration Rights Agreement, dated May 10, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Registration Rights Agreements
Fusion Pharmaceuticals Inc.
2023
Option and Asset Purchase Agreement by and between Fusion Pharmaceuticals Inc. and RadioMedix, Inc., dated November 14, 2022
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
TX
2023
Securities Purchase Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Registration Rights Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Registration Rights Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Option and Asset Purchase Agreement by and between Fusion Pharmaceuticals Inc. and RadioMedix, Inc., dated November 14, 2022
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
TX
2023
Securities Purchase Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Registration Rights Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein
Registration Rights Agreements
Fusion Pharmaceuticals Inc.
2023
Consent and First Amendment to Loan and Security Agreement, dated as of August 23, 2022, by and between Oxford Finance LLC and the Company
Loan Agreements
Fusion Pharmaceuticals Inc.
2022
Second Amendment to Loan and Security Agreement, dated as of September 21, 2022, by and between Oxford Finance LLC and the Company
Loan Agreements
Fusion Pharmaceuticals Inc.
2022
Loan and Security Agreement, dated as of April 4, 2022, by and between Oxford Finance LLC and the Company
Loan Agreements
Fusion Pharmaceuticals Inc.
2022
Employment Agreement between the Company and Mohit Rawat, dated as of September 27, 2021
Employment Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
MA
2022
Employment Agreement between the Company and Christopher Leamon, Ph.D., dated as of November 1, 2021
Employment Agreements
Fusion Pharmaceuticals Inc.
2022
Collaboration Agreement, dated December 10, 2020, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company
Collaboration Agreements
Fusion Pharmaceuticals Inc.
2021
Amendment No. 1 to Collaboration Agreement, dated June 28, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company
Collaboration Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Amendment No. 2 to Collaboration Agreement, dated July 27, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company
Collaboration Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Amendment No. 3 to Collaboration Agreement, dated August 12, 2021, by and between TRIUMF Innovations Inc. and TRIUMF JV and the Company
Collaboration Agreements
Fusion Pharmaceuticals Inc.
2021
Lease Agreement by and between Fusion Pharmaceuticals Inc. and McMaster University, dated June 1, 2021
Lease Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Fusion Pharmaceuticals Inc.
2021
Amendment No. 1 to Employment Agreement between the Company and John Valliant, dated as of February 19, 2021
Employment Agreements
Fusion Pharmaceuticals Inc.
2021
Amendment No. 1 to Employment Agreement between the Company and Eric Burak, dated as of February 19, 2021
Employment Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Amendment No. 2 to Asset Purchase Agreement, dated February 8, 2021, by and between Rainier Therapeutics, Inc. and the Company
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
First Amendment to Lease Agreement, dated as of March 16, 2021, by and between Fort Hill Square 2 Owner LLC and the Company
Lease Agreements
Fusion Pharmaceuticals Inc.
2021
Asset Purchase Agreement by and between Fusion Pharmaceuticals Inc. and Ipsen Pharma SAS, dated March 1, 2021
Purchase Agreements
Fusion Pharmaceuticals Inc.
2021
Amendment No. 1 to Asset Purchase Agreement, dated October 8, 2020, by and between Fusion Pharmaceuticals Inc. and Rainier Therapeutics, Inc
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
DE
2020
Strategic Collaboration Agreement by and between Fusion Pharmaceuticals Inc. and AstraZeneca UK Limited, dated October 30, 2020
Collaboration Agreements
Fusion Pharmaceuticals Inc.
2020
Form of Underwriting Agreement
Underwriting Agreements
Fusion Pharmaceuticals Inc.
2020
Form of Specimen Common Share Certificate
Share Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
2020 Stock Option and Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
Fusion Pharmaceuticals Inc.
2020
Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Fusion Pharmaceuticals Inc.
2020
2020 Employee Share Purchase Plan
Share Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Form of Officer Indemnification Agreement
Indemnification Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
DE
2020
Form of Director Indemnification Agreement
Indemnification Agreements
Fusion Pharmaceuticals Inc.
2020
Employment Agreement between the Registrant and John Valliant, PhD, to be in effect upon the closing of this offering
Employment Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Employment Agreement between the Registrant and John Crowley, CPA, to be in effect upon the closing of this offering
Employment Agreements
Fusion Pharmaceuticals Inc.
2020
Employment Agreement between the Registrant and Eric Burak, PhD, to be in effect upon the closing of this offering
Employment Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Amended and Restated Investors Rights Agreement among the Registrant and certain of its shareholders, dated March 25, 2019
Investor Rights Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2020
Form of Class B Preferred Exchangeable Share Purchase Warrant
Warrant Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Form of Class B Preferred Share Purchase Warrants
Share Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
2017 Equity Incentive Plan, as amended, and forms of award agreements thereunder
Bonus & Incentive Agreements
Fusion Pharmaceuticals Inc.
2020
Lease Agreement, dated as of October 1, 2019, by and between Fort Hill Square 2 Owner LLC and the Registrant
Lease Agreements
Fusion Pharmaceuticals Inc.
2020
Lease Agreement, dated as of August 1, 2018, by and between McMaster University and the Registrant
Lease Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
License Agreement, dated as of February 22, 2017, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant
License Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
License Agreement, dated as of December 19, 2016, by and between ImmunoGen, Inc. and the Registrant, as amended
License Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
MA
2020
Asset Purchase Agreement, dated as of March 10, 2020, by and between Rainier Therapeutics, Inc., Fortis Advisors LLC and the Registrant
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2020
Master Services Agreement, dated as of February 22, 2017, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant
Development Agreements
Fusion Pharmaceuticals Inc.
2020
Supply Agreement, dated as of January 17, 2019, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant
Development Agreements
Fusion Pharmaceuticals Inc.
2020